Sort
40,608 grants matching “prostate cancer”
NEW AWARD - TARGETING CASTRATION-RESISTANT PROSTATE CANCER BY ENGINEERING 3 UNTRANSLATED REGION...SIGNED 1/7/2020, EFFECTIVE 1/15/2020, DISTRIBUTED 1/8/2020, FAADC 1/8/2020...ON 1/10/2020 UPDATE # OF PROPOSALS
$321,217Duke University · · FY2020 · Defense Health Agency
Prostate Cancer: Impact of Fat &Flaxseed Modified Diet
$321,186Duke University · R01 · FY2002 · CA
SCH: Screening and confirmatory machine learning for explainable modeling of non-cancer deaths in cancer patients
$321,183Lanjing Zhang · Rutgers Biomedical And Health Sciences · R37 · FY2025 · CA
METABOLOMIC PROFILING AND BIOLOGIC BASIS OF RACIAL DISPARITY IN PROSTATE CANCER
$321,172Arun Sreekumar · Baylor College Of Medicine · U01 · FY2015 · CA
Roles of Nkx3.1 in prostate development and cancer
$321,154Cory Abate-Shen · Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2006 · CA
DCEG- Molecular Assays for epidemiology studies
$321,152Ethan Dmitrovsky · Leidos Biomedical Research, Inc. · N01 · FY2020 · CA
Genistein-mediated Regulation of Prostate Cancer Cell Motility
$321,150Raymond C Bergan · Northwestern University At Chicago · R01 · FY2008 · CA
Macro-to-micro (M2µ) Activity Apportionment for αRPT
$321,148Robert Francois Hobbs · Johns Hopkins University · P01 · FY2025 · CA
Radiobioeffect Modeling of αRPT
$321,148George Sgouros · Johns Hopkins University · P01 · FY2025 · CA
Lymphatic Imaging
$321,117Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Engineered HGF-NK1 antagonists for Met-targeted cancer imaging and therapy
$321,101Jennifer R Cochran · Stanford University · R01 · FY2012 · CA
Population mixture in evolutionary and medical genetics
$321,100David Emil Reich · Harvard Medical School · R01 · FY2012 · GM
Analyses of human T regulatory cells
$321,075Kwong Yok Tsang · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
ADJUVANT TRIAL WITH SOY AFTER RADICAL PROSTATECTOMY
$321,017Maarten C Bosland · University Of Illinois At Chicago · R01 · FY2008 · CA
Role of POZ-zinc finger proteins in tumorigenesis.
$321,009Pier Paolo Pandolfi · Beth Israel Deaconess Medical Center · R01 · FY2014 · CA
The Role of LSD1 in the Evolution of Castration Resistant Prostate Cancer
$320,971Joshi James Alumkal · Oregon Health & Science University · R01 · FY2014 · CA
Mitochondrial Heat Shock Protein 90 as a Novel Target for Radiation Resistant Prostate Cancer Treatment
$320,956Luksana Chaiswing · University Of Kentucky · P20 · FY2020 · GM
Bone matrix proteins in prostate cancer progression
$320,938University Of Southern California · R01 · FY2005 · CA
IMAGING TRANSGENE EXPRESSION IN GENE THERAPY PROTOCOLS
$320,930Sloan-Kettering Institute For Cancer Res · R01 · FY2002 · CA
Project 3 - HDAC/GSK-3B/YAP signaling network in the liver metastatic microenvironment
$320,917Stephen J Pandol · Cedars-Sinai Medical Center · P01 · FY2022 · CA
AUTOMATIC IMAGE REGISTRATION FOR PROSTATE RADIOTHERAPY
$320,883Yale University · R01 · FY2003 · EB
Role of Androgen Receptor Phosphorylation in Prostate Cancer
$320,879Daniel G Gioeli · University Of Virginia · R01 · FY2008 · CA
Small Molecule Antibody Mimics: Toward a New Paradigm in Targeted Cancer Therapy
$320,875David Adam Spiegel · Yale University · R01 · FY2012 · GM
Beta-catenin and Androgen Signaling in Prostate Cancer
$320,866Zijie Sun · Stanford University · R01 · FY2007 · DK
Immune mediated mechanisms of metastasis
$320,862Paola T Drapkin · Sanford Research/Usd · P20 · FY2018 · GM